
Sotera Health Company SHC
€ 14.34
-0.06%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Sotera Health Company EV/EBITDA 2011-2025 | SHC
EV/EBITDA Jährlich Sotera Health Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.8 | 30.7 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.7 | 24.8 | 27.8 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 16.64 | -1.95 % | $ 99.4 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 101.5 | - | $ 18.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 16.66 | 5.75 % | $ 179 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.57 | -3.4 % | $ 2 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 38.42 | -0.54 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.98 | 0.76 % | $ 340 M | ||
|
DexCom
DXCM
|
39.5 | $ 65.76 | -1.79 % | $ 25.4 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 226.02 | -0.21 % | $ 165 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 26.95 | -0.7 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 19.75 | -3.94 % | $ 1.06 B | ||
|
Celcuity
CELC
|
-2.38 | $ 103.17 | -1.98 % | $ 4.07 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 3.37 | -5.86 % | $ 107 K | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 0.31 | -9.72 % | $ 9.1 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 222.26 | 0.02 % | $ 40.3 B | ||
|
Guardant Health
GH
|
-28.8 | $ 103.49 | 1.39 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 134.29 | -0.43 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 196.54 | 1.84 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 183.1 | 0.32 % | $ 20.3 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 7.64 | -2.74 % | $ 991 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 407.75 | 0.99 % | $ 29.9 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 6.97 | -3.33 % | $ 631 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 260.62 | -1.35 % | $ 21.9 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 182.8 | -2.03 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 699.0 | -0.74 % | $ 57.6 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 12.06 | 1.73 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 6.79 | -1.09 % | $ 1.47 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 67.14 | 0.78 % | $ 4.65 B | ||
|
Agilent Technologies
A
|
27.4 | $ 140.44 | 0.56 % | $ 42.7 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.43 | -5.89 % | $ 5.58 M | ||
|
Bioventus
BVS
|
26.4 | $ 7.53 | -0.26 % | $ 472 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 2.11 | -0.47 % | $ 535 M |